By continuing to use this site you consent to the use of cookies on your device. Find out more about our cookie policy and the types of cookies we use by clicking here.

Franklin Biotechnology Discv A Acc $

Performance History30/04/2017
Growth of 1,000 (EUR)
Franklin Biotechnology Discv A Acc $
Fund57.253.416.9-15.49.2
+/-Cat6.04.9-2.51.7-0.8
+/-Idx-3.34.5-3.0-5.92.9
 
Key Stats
NAV
26/05/2017
 USD 28.84
Day Change -1.01%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
30/04/2017
 USD 2516.29
Share Class Size (Mil)
30/04/2017
 USD 2096.06
Max Initial Charge 5.75%
Ongoing Charge
27/01/2017
  1.83%
Investment Objective: Franklin Biotechnology Discv A Acc $
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns26/05/2017
YTD0.51
3 Years Annualised14.85
5 Years Annualised19.77
10 Years Annualised13.95
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Christopher Lee
15/09/2015
Click here to see others
Inception Date
03/04/2000
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Portfolio Profile for  Franklin Biotechnology Discv A Acc $30/04/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks92.850.0092.85
Bonds0.000.000.00
Cash6.040.006.04
Other1.110.001.11
Top 5 Regions%
United States96.70
United Kingdom0.94
Middle East0.89
Canada0.69
Eurozone0.62
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare9.26
Biogen IncHealthcareHealthcare6.26
Alexion Pharmaceuticals IncHealthcareHealthcare5.86
Incyte CorpHealthcareHealthcare5.63
Tesaro IncHealthcareHealthcare5.47
Franklin Biotechnology Discv A Acc $